Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy

Author:

Shen Liyun,Huang Fengjiao,Ye Lei,Zhu Wei,Zhang Xiaofang,Wang Shu,Wang Weiqing,Ning Guang

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. L. Bartalena, L. Baldeschi, A.J. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M.P. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Curro, C. Daumerie, G.J. Kahaly, G. Krassas, C.M. Lane, J.H. Lazarus, M. Marino, M. Nardi, C. Neoh, J. Orgiazzi, S. Pearce, A. Pinchera, S. Pitz, M. Salvi, P. Sivelli, M. Stahl, G. von Arx, W.M. Wiersinga, Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid 18(3), 333–346 (2008). doi: 10.1089/thy.2007.0315

2. C. Marcocci, L. Bartalena, M.L. Tanda, L. Manetti, E. Dell’Unto, R. Rocchi, G. Barbesino, B. Mazzi, M.P. Bartolomei, P. Lepri, F. Cartei, M. Nardi, A. Pinchera, Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy: results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 86(8), 3562–3567 (2001). doi: 10.1210/jcem.86.8.7737

3. G.J. Kahaly, S. Pitz, G. Hommel, M. Dittmar, Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves’ orbitopathy. J. Clin. Endocrinol. Metab. 90(9), 5234–5240 (2005). doi: 10.1210/jc.2005-0148

4. S. Zang, K.A. Ponto, G.J. Kahaly, Clinical review: intravenous glucocorticoids for Graves’ orbitopathy: efficacy and morbidity. J. Clin. Endocrinol. Metab. 96(2), 320–332 (2011). doi: 10.1210/jc.2010-1962

5. G. Vannucchi, D. Covelli, I. Campi, D. Origo, N. Curro, V. Cirello, D. Dazzi, P. Beck-Peccoz, M. Salvi, The therapeutic outcome to intravenous steroid therapy for active Graves’ orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor. Eur. J. Endocrinol. 170(1), 55–61 (2014). doi: 10.1530/EJE-13-0611

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3